EH
Equitable Holdings, Inc. (EQH)·Q1 2025 Earnings Summary
Executive Summary
- Non-GAAP operating EPS was $1.30, down 7% YoY, as elevated mortality in Protection Solutions and seasonal expense timing weighed on performance; adjusted operating EPS was $1.35 after notable items. Total revenues rose 105% YoY to $4.58B, aided by net derivative gains, while GAAP diluted EPS was $0.16 .
- Strong organic growth continued: Retirement net inflows $1.6B, Wealth Management advisory net inflows $2.0B, and AllianceBernstein net inflows $2.4B; AUM/A was ~$1.01T .
- Management reaffirmed balance sheet strength (combined NAIC RBC ~425%, HoldCo liquidity $1.1B after April actions) and expects the life reinsurance with RGA to close mid-2025, freeing >$2B capital; plans include an incremental $500M buyback post-close and lifting the quarterly dividend to $0.27 in Q2 .
- Versus S&P Global consensus, Q1 EPS missed ($1.30 vs $1.48*) on mortality/expenses, while revenue beat ($4.58B vs $3.98B*)—a mixed print that keeps near-term stock catalysts focused on the RGA close, capital deployment and sustained net flow momentum (S&P Global).*
What Went Well and What Went Wrong
What Went Well
- Retirement flows were resilient: Individual Retirement net inflows of $1.4B and Group Retirement net inflows of $192M, with IR first-year premiums up 6% YoY to $4.6B .
- AllianceBernstein delivered $2.4B net inflows and 33.7% adjusted operating margin; management highlighted durable private markets momentum (AUM $75B) and strengthened ownership to ~69% in April .
- Management emphasized robust capital and hedging posture: “We fully hedged the equity market and interest rate exposure underlying the product guarantees…protecting our capital position” .
What Went Wrong
- Protection Solutions swung to a $(17)M operating loss on elevated mortality; CFO quantified ~$80M pretax mortality above expectations, reducing EPS by ~$0.20 .
- Seasonal expense timing (benefits, payroll taxes, LTIs) pressured Individual Retirement; ~$10M pretax expense headwind should normalize next quarter .
- April market volatility weighed on near-term asset management flows (tax season, Asia retail) despite a stronger institutional pipeline for AB .
Financial Results
Consolidated metrics (oldest → newest)
Consensus vs Actual (S&P Global) — EPS and Revenue
All estimates data marked with * retrieved from S&P Global.
Segment operating earnings ($USD Millions)
KPIs and flows
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Non-GAAP operating earnings per share of $1.30, or $1.35 after adjusting for notable items… we continue to see strong organic growth momentum across our businesses” — Mark Pearson .
- “We fully hedged the equity market and interest rate exposure underlying the product guarantees…protecting our capital position” — Mark Pearson .
- “Mortality claims…came in approximately $80 million above our expectations…this underscores why we decided to reinsure 75% of our individual life block to RGA” — Robin Raju .
- “We plan to increase our quarterly cash dividend…to $0.27…and execute $500 million of incremental share repurchases post close” — Management .
Q&A Highlights
- Demand/sales: April was “robust” for RILA sales; demographic trends and need for downside protection support continued demand .
- Expenses normalization: ~$10M pretax seasonal expense in Individual Retirement should normalize in Q2; fee income remains equity-sensitive .
- Leverage & buybacks: Additional buybacks beyond $500M would likely be accompanied by debt repayment to keep leverage within rating agency expectations .
- AB flows/pipeline: April flow pressure (tax season, Asia rate uncertainty), but institutional pipeline grew by “several billion dollars” and private assets growth continues with ~$6.5B remaining commitment from EQH .
- LifePath DC income solution: ~$250M of inflows expected in Q2; timing can be lumpy .
- Spreads: IR spread income saw quarterly noise with short-rate resets; expected steady growth with general account expansion tied to RILA .
- Cash generation: FY25 at lower end of $1.6–$1.7B; 2027 $2.0B target reaffirmed, with AB ownership and RGA transaction viewed as accretive to earnings/cash per share .
- RBC post-RGA: Expect +75–100 pts increase after extraordinary dividend to HoldCo; stress test implies ample cushion .
Estimates Context
- Q1 2025: EPS missed consensus ($1.30 vs $1.48*), driven by elevated mortality and seasonal expense timing; revenue beat ($4.58B vs $3.98B*) as reported GAAP revenue included $0.80B net derivative gains (mixed non-GAAP relevance) (S&P Global).*
- Q4 2024: EPS modest miss ($1.57 vs $1.62*); revenue miss ($3.83B vs $3.98B*). Q3 2024 EPS in-line ($1.53 vs $1.53*), revenue below ($2.93B vs $3.85B*) (S&P Global).*
- Estimate counts: ~11 EPS estimates and ~5 revenue estimates across the periods (S&P Global).*
All estimates comparisons marked with * retrieved from S&P Global.
Key Takeaways for Investors
- Near-term EPS pressure from Protection Solutions mortality should abate post-RGA reinsurance close—monitor closing milestones mid-2025 and the subsequent $500M buyback execution .
- Organic growth engines are intact: sustained Retirement RILA demand, WM advisory inflows, and AB margins; April volatility effects appear transitory per AB pipeline commentary .
- Balance sheet and capital flexibility provide downside protection and optionality; RBC expected to rise +75–100 pts post-RGA while HoldCo liquidity remains >$1B after April actions .
- Dividend uplift to $0.27 and ongoing payout of 60–70% of operating earnings reinforce the capital return story; watch for leverage management alongside incremental buybacks .
- Track IR spread income trajectory and expense normalization in Q2 to confirm margin recovery; fee income remains equity-sensitive .
- AB private markets’ growth (to $75B) and broader distribution (Asia retail, private wealth) are key medium-term drivers; monitor rate path impact on flows and margins .
- Alternative investments are guided below LT targets in Q2; consider the near-term drag versus long-term 8–12% objectives .